Savi, M., Bocchi, L., Mena, P., Dall’Asta, M., Crozier, A., Brighenti, F., . . . Del Rio, D. (2017). In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetol.

Savi, Monia, Leonardo Bocchi, Pedro Mena, Margherita Dall’Asta, Alan Crozier, Furio Brighenti, Donatella Stilli, and Daniele Del Rio. "In Vivo Administration of Urolithin A and B Prevents the Occurrence of Cardiac Dysfunction in Streptozotocin-induced Diabetic Rats." Cardiovasc Diabetol 2017.

Savi, Monia, et al. "In Vivo Administration of Urolithin A and B Prevents the Occurrence of Cardiac Dysfunction in Streptozotocin-induced Diabetic Rats." Cardiovasc Diabetol 2017.